Raymond James & Associates Increases Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Raymond James & Associates raised its position in Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report) by 12.2% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 5,736 shares of the company’s stock after purchasing an additional 623 shares during the period. Raymond James & Associates’ holdings in Ryan Specialty were worth $257,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Xponance Inc. lifted its holdings in Ryan Specialty by 16.1% in the 2nd quarter. Xponance Inc. now owns 13,048 shares of the company’s stock valued at $586,000 after purchasing an additional 1,806 shares in the last quarter. Jackson Square Partners LLC purchased a new position in Ryan Specialty in the 1st quarter valued at $44,952,000. Torray Investment Partners LLC lifted its holdings in Ryan Specialty by 0.7% in the 2nd quarter. Torray Investment Partners LLC now owns 39,009 shares of the company’s stock valued at $1,751,000 after purchasing an additional 290 shares in the last quarter. Diversified Trust Co purchased a new position in Ryan Specialty in the 2nd quarter valued at $473,000. Finally, SYSTM Wealth Solutions LLC lifted its holdings in Ryan Specialty by 8.6% in the 1st quarter. SYSTM Wealth Solutions LLC now owns 51,819 shares of the company’s stock valued at $2,085,000 after purchasing an additional 4,115 shares in the last quarter. Hedge funds and other institutional investors own 34.09% of the company’s stock.

Ryan Specialty Stock Down 0.7 %

Shares of NYSE:RYAN opened at $44.41 on Friday. The business has a 50-day moving average price of $47.23 and a 200 day moving average price of $44.97. The company has a current ratio of 1.20, a quick ratio of 1.22 and a debt-to-equity ratio of 2.07. The company has a market capitalization of $11.56 billion, a price-to-earnings ratio of 94.49 and a beta of 0.46. Ryan Specialty Holdings, Inc. has a 12-month low of $32.13 and a 12-month high of $50.64.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on RYAN shares. Citigroup raised their target price on Ryan Specialty from $48.00 to $49.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 10th. JMP Securities started coverage on Ryan Specialty in a research note on Tuesday, September 19th. They issued a “market perform” rating for the company. BMO Capital Markets downgraded Ryan Specialty from an “outperform” rating to a “market perform” rating and cut their target price for the stock from $53.00 to $49.00 in a research note on Monday, October 30th. Wells Fargo & Company raised their target price on Ryan Specialty from $50.00 to $53.00 and gave the stock an “overweight” rating in a research note on Friday, August 4th. Finally, Wolfe Research started coverage on Ryan Specialty in a research note on Thursday, September 21st. They issued an “outperform” rating and a $59.00 target price for the company. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $50.43.

Read Our Latest Research Report on RYAN

Insider Activity at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 25,000 shares of the firm’s stock in a transaction dated Monday, August 14th. The stock was sold at an average price of $44.67, for a total transaction of $1,116,750.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Nicholas Dominic Cortezi sold 25,000 shares of the firm’s stock in a transaction dated Monday, August 14th. The stock was sold at an average price of $44.67, for a total transaction of $1,116,750.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Lisa Jo Paschal-Alcorn sold 42,762 shares of the firm’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $45.01, for a total value of $1,924,717.62. Following the transaction, the insider now owns 3,660 shares of the company’s stock, valued at $164,736.60. The disclosure for this sale can be found here. Insiders sold 99,247 shares of company stock worth $4,448,922 in the last three months. 54.51% of the stock is owned by company insiders.

About Ryan Specialty

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Articles

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.